- Case report
- Open Access
- Open Peer Review
Bilateral Ramsay Hunt syndrome in a diabetic patient
© Syal et al; licensee BioMed Central Ltd. 2004
- Received: 17 August 2004
- Accepted: 02 December 2004
- Published: 02 December 2004
Herpes zoster oticus accounts for about 10% cases of facial palsy, which is usually unilateral and complete and full recovery occurs in only about 20% of untreated patients. Bilateral herpes zoster oticus can sometime occur in immunocompromised patients, though incidence is very rare.
Diabetic male, 57 year old presented to us with bilateral facial palsy due to herpes zoster oticus. Patient was having bilateral mild to moderate sensorineural hearing loss. Patient was treated with appropriate metabolic control, anti-inflammatory drugs and intravenous acyclovir. Due to uncontrolled diabetes, glucocorticoids were not used in this patient. Significant improvement in hearing status and facial nerve functions were seen in this patient.
Herpes zoster causes severe infections in diabetic patients and can be a cause of bilateral facial palsy and bilateral Ramsay Hunt syndrome. Herpes zoster in diabetic patients should be treated with appropriate metabolic control, NSAIDS and intravenous acyclovir, which we feel should be started at the earliest. Glucocorticoids should be avoided in diabetic patients.
- Herpes Zoster
- Varicella Zoster Virus
- Facial Palsy
- Sensorineural Hearing Loss
- Facial Nerve Function
Varicella-zoster virus, member of Herpesviridae family has structural characteristics like a lipid envelope surrounding a nucleocapsid with icosahedral symmetry, a total diameter of 180–200 nm and centrally located double-stranded DNA about 125,000 bp in length. Varicella-zoster virus lies latent in sensory root ganglion for years in a patient who had chickenpox earlier. Some precipitating factor may reactivate it especially when immunity of patient wanes leading to Herpes zoster, a sporadic disease. Involvement of geniculate ganglion of sensory branch of facial nerve leads to Herpes zoster oticus also known as Ramsay Hunt syndrome. Involvement of facial nerve leads to otalgia, lower motor neuron homolateral facial paralysis and vesicular eruptions in auricle and external auditory canal. In severe cases of herpes zoster oticus, involvement of vestibulocochlear nerve leads to sensorineural hearing loss in 10% and vestibular symptoms in 40% patients. Herpes zoster oticus accounts for 10% cases of the facial palsy, paralysis is usually complete and full recovery occurs in only about 20% of untreated patients .
Herpes zoster rash is characterized by unilateral vesicular eruptions with in a single dermatome. In 16% of patients of zoster, vesicles develop beyond single dermatome . Onset of disease is heralded by pain with in dermatome that may precede lesions by 48–72 hrs; total duration of disease is 7–10 days. In immunocompromised and elderly patients course of herpes zoster is more prolonged and severe. Rarely in such patients zoster may successively involve further dermatomes.
Considering, rarity of bilateral herpes zoster, a diabetic patient presenting with bilateral Ramsay Hunt syndrome is being reported here.
Diabetic male, 57 year old presented to us with history of pain in left ear for the last 8 days. 48–72 hrs after the onset of otalgia, patient developed facial weakness on left side along with vesicular eruptions on left conchae and in left external auditory meatus. After another 24–48 hrs patient had similar episode on right side. On the day of reporting to us patient was having bilateral facial weakness, impaired taste sensation, dryness of eyes along with decreased hearing on both sides but there was no history of vertigo or any ear discharge. There was history of stressful life events in past 6 months before the onset of rash.
The patient was admitted and investigated. His postprandial blood sugar was 339 mg%, HbAIc was 7%. Pure tone audiometery was showing mild to moderate bilateral sensorineural hearing loss, stapedial reflexes were absent on both sides on tympanometery. There was impaired taste sensation from anterior two third of tongue. ELISA and Western Blot tests for HIV infection were negative. Liver function tests, tumor markers, thyroid hormones; serum ACE levels were all with in normal limits. Lumbar puncture revealed normal pressure. Glucose, protein and white blood cell count were all with in normal limits in CSF. Plain X-ray views of mastoid, internal auditory meatus and chest were normal. Computerized tomography of brain stem, cerebellopontine angle, temporal bone and skull base were normal. A smear from floor of vesicle stained with Giemsa stain showed degenerating cells with multiple nuclei. This favoured the clinical diagnosis of herpes zoster oticus. This diagnosis was confirmed by detection of IgM antibodies to Varicella-Zoster virus by ELISA test.
Severity and incidence of herpes zoster increases in elderly and in immunomodulated state like in AIDS, lymphoproliferative disorders, disseminated carcinomatosis, diabetes, during steroid therapy, during radio or chemotherapy . Kubeyinje EP.(1995) found that varicella runs more aggressive course in diabetic patients as compared to otherwise healthy individuals . Neu I et al (1977)in their study found basal metabolic disorders especially diabetes of particular significance inactivation and in primary and secondary manifestations of varicella zoster virus . Muller C. et al (1989) concluded that metabolic derangement in diabetes leads to reversible disturbance in certain cellular immune functions which can be normalized by good metabolic control achieved by insulin treatment . Postprandial blood sugar of our patient was 330 mg% at time of presentation and HbA1c was 7.0%, so blood sugar control was not appropriate in this patient. Patient was also under severe psychological stress since last 6 months and psychological stress is identified as a potential risk factor for zoster that might operate by suppressing cell-mediated immunity . So uncontrolled diabetes and psychological stress were two risk factors present in this patient, making him prone for severe and recurrent infection of herpes zoster.
Hiroshige K et al (2002) conducted a study based on detection of varicella zoster virus DNA in tear fluid and saliva of patients with Ramsay Hunt syndrome and concluded that varicella zoster virus reactivation occurs in the unaffected side at the same level as in the affected side . This explains the occurrence of bilateral Ramsay Hunt syndrome due to herpes zoster oticus in this patient. Shoji H et al (1980) also suggested that in Ramsay Hunt syndrome and its subgroups, bilateral involvement or wide spread of infection through nervous tissue can occur though its incidence is very rare.
In the management part, as metabolic control of diabetes improves leukocyte functions and overall immune status of patient  so insulin was started and dose was adjusted to achieve good metabolic control. As incidence of severe and disseminated infections of Herpes zoster is more in diabetes so intravenous acyclovir in dose of 10 mg/kg every 8 hr for 7 days was given. Recent reports suggest that treatment with i.v acyclovir decreases the incidence of permanent facial nerve palsy in Ramsay Hunt Syndrome. Results of relevant control trials have not yet been published . Glucocorticoid therapy usually used in facial palsy due to herpes zoster oticus was avoided in this patient due to uncontrolled diabetes but NSAIDS and other analgesics were given in this patient.
On follow up of this patient, facial nerve recovered on both sides, recovery was more on right side. This was documented by electroneurography which showed greater amplitude of muscle compound action potentials on right side as compared to left. This might have been due to lesser time gap between the onset of acyclovir therapy and attack of zoster oticus on right side. Time gap between the onset of acyclovir therapy and attack of zoster oticus is most relevant prognostic factor in recovery of these patients and this hypothesis is supported by findings in studies of Mcgrath N. (1997) , Raschilas F (2002)  and Strupp M. et al (2004) . There was also a significant improvement in hearing status of patient. This result was in accordance with other studies which keep age 64 years or younger, mild initial hearing loss, a cochlear pattern of hearing loss and absence of vertigo as factors favorable for recovery of auditory function .
Herpes zoster can cause severe infections in diabetic patient and can cause bilateral facial palsy and bilateral Ramsay Hunt syndrome.
-Herpes zoster in diabetic patients should be treated with appropriate metabolic control, NSAIDS and intravenous acyclovir, which we feel should be started at the earliest.
-Intravenous acyclovir therapy in cases of herpes zoster oticus is effective in control of disease and prevents the incidence of permanent facial palsy but treatment should be started early in the course of disease preferably with in 72 hrs from start of disease.
-Glucocorticoids should be avoided in Herpes zoster patients having uncontrolled diabetes.
Written informed consent has been taken from patient and he has no objection in publication of this case report and his photographs.
- Sterling JC, Kurtz JB: Viral infections. In Textbook of Dermatology, Rook/ Wilkinson/ Ebling. Edited by: Champion RH, Burton JL, Burns DA, Breathnach SM. 1998, Blackwell Science Ltd, Oxford, 2: 1015-21. 6Google Scholar
- Anderson M: Virus infections of the nervous system. In brain's diseases of nervous system. Edited by: Walton J. 1993, Oxford University Press, Oxford, 317-50. 10Google Scholar
- Kubeyinje EP: Severity of varicella infection in Saudis with diabetes mellitus: a possible role of acyclovir in treatment. East Afr Med J. 1995, 72 (11): 739-741.PubMedGoogle Scholar
- Neu I, Rodiek S: Significance of diabetes mellitus in the activation of the varicella zoster virus (author's transl). MMW Munch Med Wochenschr. 1977, 119 (16): 543-6.PubMedGoogle Scholar
- Muller C, Zielinski CC, Kalinowski W, Wolf H, Mannhalter JW, Aschauer-Treiber G, Klosch-Kasparek D, Gaube S, Eibl MM, Schernthaner G: Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study. J Endocrinol. 1989, 121 (1): 177-83.View ArticlePubMedGoogle Scholar
- Schmader K, Studenski S, MacMillan J, Grufferman S, Cohen HJ: Are stressful life events risk factors for herpes zoster?. JAM Geriatr Soc. 1990, 38: 1188-1194.View ArticleGoogle Scholar
- Hiroshige K, Ikeda M, Hondo R: Detection of varicella zoster virus DNA in tear fluid and saliva of patients with Ramsay Hunt syndrome. Otol Neurotol. 2002, 23 (4): 602-7. 10.1097/00129492-200207000-00034.View ArticlePubMedGoogle Scholar
- Shoji H, Hirose K, Uono M, Koya M: A case of facial diplegi following herpes zoster ophthalmicus. Eur Neurol. 1980, 19 (5): 327-9.View ArticlePubMedGoogle Scholar
- Durand M, Joseph M, Baker AS: Infections of upper respiratory tract. In Harrison's principles of internal medicine. Edited by: Fauci AS, Martin JB, Braunwald E, Kasper DL, Isselbacher KJ, Hauser SL, Wilson JD, Longo DL. 1998, McGraw-Hill Health Professions Division, London, 1: 181-14Google Scholar
- McGrath N, Anderson NE, Croxson MC, Powell KF: Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997, 63: 321-6.View ArticlePubMedPubMed CentralGoogle Scholar
- Raschilas F, Wolff M, Delatour F, Chaffaut C, Broucker TD, Chevret S, Lebon P, Canton P, Rozenberg F: Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis. 2002, 35: 254-60. 10.1086/341405.View ArticlePubMedGoogle Scholar
- Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, Bense S, Theil D, Jahn K, Brandt T: Methylprednisolone, Valacyclovir, or the Combination for Vestibular Neuritis. N Engl J Med. 2004, 351 (4): 354-61. 10.1056/NEJMoa033280.View ArticlePubMedGoogle Scholar
- Byl FM, Adour KK: Auditory symptoms associated with herpes zoster or idiopathic facial paralysis. Laryngoscope. 1977, 87 (3): 372-9.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6815/4/3/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.